AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
Feb 16, 2011
30016_dirs_2011-02-16_5d1840a5-1c09-4bf2-9c22-57c198a7a910.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-02-14
Reporting Person: MCKEON BRIAN P (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-14 | Deferred Stock Unit | $ | A | 354 | Acquired | Common Stock (354) | Direct | |
| 2011-02-14 | Non-Qualified Stock Option (right to buy) | $77.59 | A | 3301 | Acquired | 2018-02-13 | Common Stock (3301) | Direct |
Footnotes
F1: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest 100% one year from the date of grant and are payable as common stock one year following the Director's resignation from the Board of Directors.
F2: Grant of options to buy shares of common stock that vest one year from the date of grant (02/14/2012).
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13